LEADER 01722nam  2200409 a 450 
001 9910699068703321
005 20090813121455.0
035   $a(CKB)5470000002399197
035   $a(OCoLC)430343417
035   $a(EXLCZ)995470000002399197
100   $a20090813d2009      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPrescription drugs$b[electronic resource] $eoverview of approaches to control prescription drug spending in federal programs : testimony before the Subcommittee on Federal Workforce, Postal Service, and the District of Columbia, Committee on Oversight and Government Reform, House of Representatives /$fstatement of John E. Dicken
210  1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2009]
215   $a1 online resource (14 pages)
225 1 $aTestimony ;$vGAO-09-819T
300   $aTitle from title screen (GAO, viewed July 22, 2009).
300   $a"For release ... June 24, 2009."
320   $aIncludes bibliographical references.
517   $aPrescription drugs 
606   $aDrugs$zUnited States$xCost control
606   $aDrugs$zUnited States$xFinance
615  0$aDrugs$xCost control.
615  0$aDrugs$xFinance.
700   $aDicken$b John E$01382684
712 02$aUnited States.$bCongress.$bHouse.$bCommittee on Oversight and Government Reform.$bSubcommittee on Federal Workforce, Postal Service, and the District of Columbia.
712 02$aUnited States.$bGovernment Accountability Office.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910699068703321
996   $aPrescription drugs$93435639
997   $aUNINA